Nox4 in renal diseases: An update

Q Yang, F Wu, J Wang, L Gao, L Jiang, HD Li… - Free Radical Biology …, 2018 - Elsevier
Reactive oxygen species derived from NADPH oxidase contribute to a wide variety of renal
diseases. Nox4, the major NADPH isoform in kidney, produces mainly H 2 O 2 that regulates …

[HTML][HTML] Small molecules from natural products targeting the Wnt/β-catenin pathway as a therapeutic strategy

D Liu, L Chen, H Zhao, ND Vaziri, SC Ma… - Biomedicine & …, 2019 - Elsevier
The Wnt/β-catenin signaling pathway is an evolutionarily conserved developmental
signaling event that plays a critical role in regulating tissue development and maintaining …

Perfluorooctane sulfonate‐induced apoptosis in kidney cells by triggering the NOX4/ROS/JNK axis and antagonism of cannabidiol

Y Du, T Xu, D Luo, Y Wang, H Yin… - Environmental …, 2023 - Wiley Online Library
Perfluorooctane sulfonate (PFOS) is one of the persistent organic pollutants (POPs), which
can cause severe nephrotoxicity in mammals. Cannabinol (CBD), a nonpsychoactive …

[HTML][HTML] NADPH oxidase 4 promotes cisplatin-induced acute kidney injury via ROS-mediated programmed cell death and inflammation

XM Meng, GL Ren, L Gao, Q Yang, HD Li… - Laboratory …, 2018 - nature.com
The goal of this study was to elucidate the functional role of Nox4 during acute kidney injury
(AKI). NADPH oxidases are a major source of reactive oxygen species (ROS) in the kidney …

[HTML][HTML] NOX4 is a potential therapeutic target in septic acute kidney injury by inhibiting mitochondrial dysfunction and inflammation

J Li, L Wang, B Wang, Z Zhang, L Jiang, Z Qin… - Theranostics, 2023 - ncbi.nlm.nih.gov
Rationale: Sepsis is a severe clinical syndrome featured through organ dysfunction due to
infection, while the accompanying acute kidney injury (AKI) is linked to significant incidence …

[HTML][HTML] Carvedilol (CAR) combined with carnosic acid (CAA) attenuates doxorubicin-induced cardiotoxicity by suppressing excessive oxidative stress, inflammation …

QL Zhang, JJ Yang, HS Zhang - Biomedicine & Pharmacotherapy, 2019 - Elsevier
Doxorubicin (DOX) is a wide spectrum antitumor drug. However, its clinical application is
limited due to the cardiotoxicity. Carvedilol (CAR) is a β-blocker used to treat high blood …

[HTML][HTML] Brd4 inhibition attenuates unilateral ureteral obstruction-induced fibrosis by blocking TGF-β-mediated Nox4 expression

B Zhou, J Mu, Y Gong, C Lu, Y Zhao, T He, Z Qin - Redox biology, 2017 - Elsevier
Uncovering new therapeutic targets for renal fibrosis holds promise for the treatment of
chronic kidney diseases. Bromodomain and extra-terminal (BET) protein inhibitors have …

[HTML][HTML] Inhibition of p300/CBP-associated factor attenuates renal tubulointerstitial fibrosis through modulation of NF-kB and Nrf2

S Chung, S Kim, M Son, M Kim, ES Koh… - International journal of …, 2019 - mdpi.com
p300/CBP-associated factor (PCAF), a histone acetyltransferase, is involved in many cellular
processes such as differentiation, proliferation, apoptosis, and reaction to cell damage by …

[HTML][HTML] Protective Effects of Carnosol on Renal Interstitial Fibrosis in a Murine Model of Unilateral Ureteral Obstruction

JH Park, J Leem, SJ Lee - Antioxidants, 2022 - mdpi.com
Renal fibrosis is a common feature of chronic kidney disease and is a promising therapeutic
target. However, there is still limited treatment for renal fibrosis, so the development of new …

Rosmarinic acid ameliorates renal interstitial fibrosis by inhibiting the phosphorylated-AKT mediated epithelial–mesenchymal transition in vitro and in vivo

YH Hsieh, JP Tsai, YH Ting, TW Hung, WW Chao - Food & Function, 2022 - pubs.rsc.org
Indoxyl sulfate (IS), a uremic toxin, causes chronic kidney disease (CKD) progression via
renal fibrosis. Epithelial–mesenchymal transition (EMT) is a crucial feature of renal fibrosis …